Capecitabine

CAS 154361-50-9 20 current records 12 historicalSmall Molecule

Who holds supplier records for Capecitabine? 20 organisations hold a current record for Capecitabine: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), China (3), Taiwan (1), Netherlands (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Capecitabine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/capecitabine

Reading the evidence

  • 20 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (20)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Capecitabine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India12China3Taiwan1Netherlands1Italy1Country not recorded for 2
  • Intas Pharmaceuticals Ltd.
    Active DMF 24370, 33574 · latest filing Mar 2019
    IndiaCEP Company GMP cert on record
  • CDYMAX (INDIA) PHARMA PRIVATE LIMITED
    Active DMF 25054 · latest filing Jun 2011
    IndiaCEP Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 28538, 22479 · latest filing Sept 2014
    IndiaCEP Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 22140 · latest filing Oct 2008
    IndiaCEP Company GMP cert on record
  • MSN Laboratories Private Limited
    Active DMF 26078 · latest filing May 2012
    IndiaCEP Company GMP cert on record
  • SCINOPHARM TAIWAN LTD
    Active DMF 24126 · latest filing Aug 2010
    TaiwanCEP
  • Shandong Anxin Pharmaceutical Co., Ltd.
    Active DMF 27085 · latest filing Apr 2013
    ChinaCEP Company GMP cert on record
  • SHILPA PHARMA LIFESCIENCES LTD
    Active DMF 24689 · latest filing Mar 2011
    IndiaCEP
  • Sun Pharmaceutical Industries Limited
    Active DMF 26018 · latest filing Jul 2012
    IndiaCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 29209 · latest filing Nov 2015
    NetherlandsCEP
  • Vannsh Life Sciences Private Limited
    Active DMF 39563 · latest filing Jun 2024
    IndiaCEP
  • AARTI PHARMALABS LIMITED
    Active DMF 22954 · latest filing Jul 2009
    India
  • ARCHIMICA SPA
    Active DMF 25266 · latest filing Sept 2011
    Italy Company GMP cert on record
  • DIVI'S LABOTATORIES LTD
    Active DMF 22157 · latest filing Oct 2008
  • EMNAR PHARMA PRIVATE LTD
    Active DMF 41855 · latest filing May 2025
    India
  • LIANYUNGANG GUIKE PHARMACEUTICAL CO LTD
    Active DMF 26818 · latest filing Jan 2013
  • Reliance Life Sciences Pvt. Ltd.
    Active DMF 23808 · latest filing May 2010
    India Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • ChinaCEP
  • Shandong Lixin Pharmaceutical Co., Ltd.
    ChinaCEP
Need Capecitabine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Capecitabine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 27 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
INTAS PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2025-176 - Rev 02
Capecitabine, Process-III
Oct 2026—
HETERO LABS LIMITED HyderabadIN
CEP 2026-173 - Rev 00
Capecitabine, Site-II
May 2026—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2016-140 - Rev 01
Capecitabine
Mar 2026—
TAPI NL B.V. AmsterdamNL
CEP 2015-078 - Rev 01
Capecitabine
Jul 2025—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2014-332 - Rev 03
Capecitabine
Jun 2025—
VANNSH LIFE SCIENCES PRIVATE LIMITED VisakhapatnamIN
CEP 2021-505 - Rev 00
Capecitabine
Feb 2025—
SHANDONG ANXIN PHARMACEUTICAL CO., LTD Dongjia TownCN
CEP 2014-189 - Rev 04
Capecitabine
Nov 2024Inspected Sept 2023
Austria, outside 3-year window
SCINOPHARM TAIWAN LTD. Shan-HuaTW
CEP 2018-015 - Rev 01
Capecitabine
Mar 2024—
MSN LABORATORIES PRIVATE LIMITED Kardanur VillageIN
R1-CEP 2015-391 - Rev 02
Capecitabine
Aug 2023—
SHANDONG BOYUAN PHARMACEUTICAL CO., LTD. Jinan CityCN
R1-CEP 2014-343 - Rev 01
Capecitabine
Aug 2023—
SHANDONG LIXIN PHARMACEUTICAL CO. LTD. ZiboCN
R0-CEP 2021-316 - Rev 00
Capecitabine
Oct 2022—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2014-109 - Rev 02
Capecitabine
Sept 2022—
CDYMAX (INDIA) PHARMA PRIVATE LIMITED BangaloreIN
R1-CEP 2013-309 - Rev 03
Capecitabine
Sept 2021—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2015-111 - Rev 00
Capecitabine
Apr 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (12)

Organisations whose Type II DMFs for Capecitabine are no longer active. These show a past filing, not current supply.

Show all 12 historical records
  • SIGNA SA DE CV
    Inactive DMF 30543 · filed Jun 2016
  • MAC CHEM PRODUCTS INDIA PVT LTD
    Inactive DMF 27026 · filed Apr 2013
  • China · Inactive DMF 26993 · filed Mar 2013
  • Sichuan Xieli Pharmaceutical Co Ltd
    China · Inactive DMF 26403 · filed Sept 2012
  • Apotex Pharmachem India Pvt. Ltd.
    India · Inactive DMF 25720 · filed Jan 2012
  • China · Inactive DMF 25521 · filed Nov 2011
  • Zhejiang Cheng Yi Pharmaceutical Co., Ltd
    China · Inactive DMF 25592 · filed Nov 2011
  • India · Inactive DMF 24517 · filed Jan 2011
  • QILU TIANHE PHARMACEUTICAL CO LTD
    Inactive DMF 24529 · filed Dec 2010
  • MYLAN LABORATORIES LTD
    Inactive DMF 23685 · filed Apr 2010
  • India · Inactive DMF 21620 · filed Aug 2009
  • JIANGSU ZW PHARMACEUTICALS CO LTD
    Inactive DMF 22014 · filed Aug 2008

Overview

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of various cancers, most notably colorectal and breast cancer. It is a prodrug that is metabolized to 5-fluorouracil, a molecule that inhibits thymidylate synthase, thereby blocking DNA synthesis in rapidly dividing tumor cells.

Chemical identity

IUPAC name
pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
Canonical SMILES
CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O
InChIKey
GAGWJHPBXLXJQN-UORFTKCHSA-N
Synonyms
Xeloda API, capecitabine accord, capecitabine medac, capecitabine sun, capecitabine teva, capecitibine, capecytabine, capiibine, captabin, ecansya, nsc-759853, ro 09-1978/000

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Nucleoside Metabolic Inhibitor
Mechanism of action
Nucleic Acid Synthesis Inhibitors

Therapeutic areas

Oncology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Capecitabine?

20 organisations hold an active US FDA Type II Drug Master File or a CEP for Capecitabine: Intas Pharmaceuticals Ltd. (India), CDYMAX (INDIA) PHARMA PRIVATE LIMITED (India), Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), MSN Laboratories Private Limited (India), SCINOPHARM TAIWAN LTD (Taiwan), Shandong Anxin Pharmaceutical Co., Ltd. (China) and SHILPA PHARMA LIFESCIENCES LTD (India), and 12 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Capecitabine Drug Master Files are active?

Intas Pharmaceuticals Ltd. (DMF 24370, 33574), CDYMAX (INDIA) PHARMA PRIVATE LIMITED (DMF 25054), Dr. Reddy's Laboratories Ltd. (DMF 28538, 22479), Hetero Labs Limited (DMF 22140), MSN Laboratories Private Limited (DMF 26078), SCINOPHARM TAIWAN LTD (DMF 24126), Shandong Anxin Pharmaceutical Co., Ltd. (DMF 27085) and SHILPA PHARMA LIFESCIENCES LTD (DMF 24689) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Capecitabine records mean?

12 organisations have only inactive Type II DMFs for Capecitabine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Capecitabine have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Capecitabine on the EDQM register, including INTAS PHARMACEUTICALS LIMITED Ahmedabad (IN), HETERO LABS LIMITED Hyderabad (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), TAPI NL B.V. Amsterdam (NL), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN) and VANNSH LIFE SCIENCES PRIVATE LIMITED Visakhapatnam (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Capecitabine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Capecitabine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.